Extracellular vesicle-encapsulated miR-22-3p from bone marrow mesenchymal stem cell promotes osteogenic differentiation via FTO inhibition
Authors:
Open Access
- 10 June 2020
- journal article
- research article
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 11 (1) , 1-14
Abstract
Background: Bone marrow mesenchymal stem cells (BMSCs) exhibit the capacity to self-renew and differentiate into multi-lineage cell types, including osteoblasts, which are crucial regulators of fracture healing. Thus, this study aims to investigate the effect of microRNA (miR)-22-3p from BMSC-derived EVs on osteogenic differentiation and its underlying mechanism. Methods: Extracellular vesicles (EVs) were isolated from BMSCs and taken up with BMSCs. Dual-luciferase reporter gene assay was used to verify the binding relationship between miR-22-3p and FTO. Loss- and gain-of-function experiments were performed to determine the roles of EV-delivered miR-22-3p and FTO in osteogenic differentiation as well as their regulatory role in the MYC/PI3K/AKT axis. To determine the osteogenic differentiation, ALP and ARS stainings were conducted, and the levels of RUNX2, OCN, and OPN level were determined. In vivo experiment was conducted to determine the function of EV-delivered miR-22-3p and FTO in osteogenic differentiation, followed by ALP and ARS staining. Results: miR-22-3p expression was repressed, while FTO expression was elevated in the ovariectomized mouse model. Overexpression of miR-22-3p, EV-delivered miR-22-3p, increased ALP activity and matrix mineralization of BMSCs and promoted RUNX2, OCN, and OPN expressions in BMSCs. miR-22-3p negatively targeted FTO expression. FTO silencing rescued the suppressed osteogenic differentiation by EV-delivered miR-22-3p inhibitor. FTO repression inactivated the MYC/PI3K/AKT pathway, thereby enhancing osteogenic differentiation both in vivo and in vitro. Conclusion: In summary, miR-22-3p delivered by BMSC-derived EVs could result in the inhibition of the MYC/PI3K/AKT pathway, thereby promoting osteogenic differentiation via FTO repression.Keywords
This publication has 32 references indexed in Scilit:
- miR-149-3p Regulates the Switch between Adipogenic and Osteogenic Differentiation of BMSCs by Targeting FTOMolecular Therapy Nucleic Acids, 2019
- Osteogenic effect of bone marrow mesenchymal stem cell-derived exosomes on steroid-induced osteonecrosis of the femoral headDrug Design, Development and Therapy, 2018
- The GDF11-FTO-PPARγ axis controls the shift of osteoporotic MSC fate to adipocyte and inhibits bone formation during osteoporosisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2018
- Targeting oncogenic Myc as a strategy for cancer treatmentSignal Transduction and Targeted Therapy, 2018
- Shedding light on the cell biology of extracellular vesiclesNature Reviews Molecular Cell Biology, 2018
- Synergetic effect of topological cue and periodic mechanical tension-stress on osteogenic differentiation of rat bone mesenchymal stem cellsColloids and Surfaces B: Biointerfaces, 2017
- Bone marrow stromal/stem cell-derived extracellular vesicles regulate osteoblast activity and differentiation in vitro and promote bone regeneration in vivoScientific Reports, 2016
- Differentially circulating miRNAs after recent osteoporotic fractures can influence osteogenic differentiationBone, 2015
- The effect of type II collagen on MSC osteogenic differentiation and bone defect repairBiomaterials, 2014
- MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivoProceedings of the National Academy of Sciences, 2011